-
-
-
-
-
-
-
Raymond James: 'WVE regains full economic rights to WVE-006 from GSK'
-
-
-
-
-
-
-
WAVE Life Sciences (WVE) PT Raised to $32 at Oppenheimer
-
-
-
-
-
-
-
Increasing unusual call option volume: WVE WRBY CRH PLAB AMLP AM CNM ELAN GPCR
-
-
-
-
-
-
-
Truist: 'QURE Update Minimal Read-Through To PTCT & WVE, In Our View'
-
-
-
-
-
-
-
Wave Life Sciences reports positive data from AATD drug trial
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on WAVE Life Sciences (WVE)
-
-
-
-
-
-
-
Cantor Fitzgerald Starts WAVE Life Sciences (WVE) at Overweight
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

